Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome

Annals of the Rheumatic Diseases

Volumn 67, Issue 6, 2008, Pages 894-895

  Salama, A ^a   Schneider, U ^a   Dörner, Thomas ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AUTOANTIBODY; CHLOROQUINE; CYCLOSPORIN; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADULT; ANTIBODY DETECTION; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; FATIGUE; FELTY SYNDROME; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKOCYTE; LEUKOCYTE COUNT; MYELODYSPLASIA; NEUTROPENIA; POLYARTHRITIS; PRIORITY JOURNAL; RETICULOCYTOSIS; SPLENOMEGALY; THROMBOCYTE; THROMBOCYTOPENIA;

ADULT; ANEMIA, HEMOLYTIC; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FELTY'S SYNDROME; FEMALE; HUMANS;

EID: 45149097976     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.077966     Document Type: Letter

References (5)

1. Burks EJ, Loughran TP. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood 2006;20:245-66.
2. Hume R, Dagg JH, Fraser TN, Goldberg A. Anaemia of Felty syndrome. Ann Rheum Dis 1964;23:267-71.
3. Rashba EJ, Rowe JM, Packman CH: Treatment of the neutropenia of Felty syndrome. Blood 1996;10:177-84.
4. Sordet C, Gottenberg JE, Hellmich B, Kieffer P, Mariette X, Sibilia J. Lack of efficacy of rituximab in Felty's syndrome. Ann Rheum Dis 2005;64:332-3.
5. Weinreb N, Rabinowitz A, Dellaripa P: Beneficial response to rituximab in refractory Felty syndrome. JCR 2006;12:48.